HS Code:
3-Phenyl-5-(2-thienyl)-1,2,4-oxadiazole, commonly known as Tioxazafen (CAS No. 330459-31-9), is a chemical compound classified under HS Code 2934.99.18, which covers other heterocyclic compounds. Tioxazafen is primarily used as a nematicide in agricultural applications to protect crops from nematode pests. It is a niche product within the agrochemical industry, with limited but specialized global trade due to its specific application in crop protection. The compound is part of the broader category of heterocyclic compounds with oxygen and nitrogen hetero-atoms, often utilized in pharmaceuticals and pesticides.
Total Trade Volume
Approximately $15 million USD
Data from 2022
Source
Estimated based on data from UN Comtrade and industry reports
$6 million USD
40% of total trade of total trade
Increasing
$3 million USD
20% of total trade of total trade
Stable
$2.5 million USD
17% of total trade of total trade
Increasing
$1.5 million USD
10% of total trade of total trade
Stable
$1 million USD
7% of total trade of total trade
Increasing
Average Rate
5.5% ad valorem
Highest Rate
8% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements or WTO bindings in select markets)
Growing demand for nematicides in agriculture
Increased trade volume as farmers seek effective solutions for nematode control in high-value crops like soybeans and corn
2021-2022
Shift toward sustainable agrochemicals
Potential reduction in demand for synthetic compounds like Tioxazafen if bio-based alternatives gain traction
2022-2023
Regulatory tightening in key markets
Stricter regulations in the EU and North America may limit market access or increase compliance costs for exporters
2020-2022
Tioxazafen received updated approval from the US Environmental Protection Agency (EPA) for use in additional crops, boosting its market potential.
March 2022
Expected to increase US imports and domestic production by 15% over the next two years.
The European Union initiated a review of Tioxazafen under its pesticide regulation framework due to environmental concerns.
September 2022
Possible temporary suspension of imports into EU markets pending review outcomes, affecting trade flows.
Chinese manufacturers have ramped up production capacity for Tioxazafen to meet growing demand in Asia-Pacific markets.
January 2023
Likely to lower global prices due to increased supply, benefiting importing countries like India and Brazil.